Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SCCA1 synapses in the hippocampus

Rebecca Klar, Adam G. Walker, Dipanwita Ghose, Brad A. Grueter, Darren W. Engers, Corey R Hopkins, Craig W. Lindsley, Zixiu Xiang, P. Jeffrey Conn, Colleen M. Niswender

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Of the eight metabotropic glutamate (mGlu) receptor subtypes, only mGlu7 is expressed presynaptically at the Schaffer collateral (SC)-CA1 synapse in the hippocampus in adult animals. Coupled with the inhibitory effects of Group III mGlu receptor agonists on transmission at this synapse, mGlu7 is thought to be the predominant autoreceptor responsible for regulating glutamate release at SC terminals. However, the lack of mGlu7-selective pharmacological tools has hampered direct testing of this hypothesis. We used a novel, selective mGlu7-negative allosteric modulator (NAM), ADX71743, and a newly described Group III mGlu receptor agonist, LSP4-2022, to elucidate the role of mGlu7 in modulating transmission in hippocampal area CA1 in adult C57BL/6J male mice. Interestingly, although mGlu7 agonists inhibit SC-CA1 EPSPs, we found no evidence for activation of mGlu7 by stimulation of SC-CA1 afferents. However, LSP4-2022 also reduced evoked monosynaptic IPSCs in CA1 pyramidal cells and, in contrast to its effect on SC-CA1 EPSPs, ADX71743 reversed the ability of high-frequency stimulation of SC afferents to reduce IPSC amplitudes. Furthermore, blockade of mGlu7 prevented induction of LTP at the SC-CA1 synapse and activation of mGlu7 potentiated submaximal LTP. Together, these data suggest that mGlu7 serves as a heteroreceptor at inhibitory synapses in area CA1 and that the predominant effect of activation of mGlu7 by stimulation of glutamatergic afferents is disinhibition, rather than reduced excitatory transmission. Furthermore, this mGlu7-mediated disinhibition is required for induction of LTP at the SC-CA1 synapse, suggesting that mGlu7 could serve as a novel therapeutic target for treatment of cognitive disorders.

Original languageEnglish (US)
Pages (from-to)7600-7615
Number of pages16
JournalJournal of Neuroscience
Volume35
Issue number19
DOIs
StatePublished - May 13 2015

Fingerprint

Long-Term Potentiation
Synapses
Hippocampus
Metabotropic Glutamate Receptors
Excitatory Amino Acid Agonists
Excitatory Postsynaptic Potentials
metabotropic glutamate receptor 7
Autoreceptors
Pyramidal Cells
Glutamic Acid
Pharmacology

Keywords

  • Glutamate
  • Hippocampus
  • LTP
  • mGlu
  • mGlu7
  • mGlur7

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SCCA1 synapses in the hippocampus. / Klar, Rebecca; Walker, Adam G.; Ghose, Dipanwita; Grueter, Brad A.; Engers, Darren W.; Hopkins, Corey R; Lindsley, Craig W.; Xiang, Zixiu; Conn, P. Jeffrey; Niswender, Colleen M.

In: Journal of Neuroscience, Vol. 35, No. 19, 13.05.2015, p. 7600-7615.

Research output: Contribution to journalArticle

Klar, R, Walker, AG, Ghose, D, Grueter, BA, Engers, DW, Hopkins, CR, Lindsley, CW, Xiang, Z, Conn, PJ & Niswender, CM 2015, 'Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SCCA1 synapses in the hippocampus', Journal of Neuroscience, vol. 35, no. 19, pp. 7600-7615. https://doi.org/10.1523/JNEUROSCI.4543-14.2015
Klar, Rebecca ; Walker, Adam G. ; Ghose, Dipanwita ; Grueter, Brad A. ; Engers, Darren W. ; Hopkins, Corey R ; Lindsley, Craig W. ; Xiang, Zixiu ; Conn, P. Jeffrey ; Niswender, Colleen M. / Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SCCA1 synapses in the hippocampus. In: Journal of Neuroscience. 2015 ; Vol. 35, No. 19. pp. 7600-7615.
@article{f8f9f2babc2d463d9c7f7b532d127062,
title = "Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SCCA1 synapses in the hippocampus",
abstract = "Of the eight metabotropic glutamate (mGlu) receptor subtypes, only mGlu7 is expressed presynaptically at the Schaffer collateral (SC)-CA1 synapse in the hippocampus in adult animals. Coupled with the inhibitory effects of Group III mGlu receptor agonists on transmission at this synapse, mGlu7 is thought to be the predominant autoreceptor responsible for regulating glutamate release at SC terminals. However, the lack of mGlu7-selective pharmacological tools has hampered direct testing of this hypothesis. We used a novel, selective mGlu7-negative allosteric modulator (NAM), ADX71743, and a newly described Group III mGlu receptor agonist, LSP4-2022, to elucidate the role of mGlu7 in modulating transmission in hippocampal area CA1 in adult C57BL/6J male mice. Interestingly, although mGlu7 agonists inhibit SC-CA1 EPSPs, we found no evidence for activation of mGlu7 by stimulation of SC-CA1 afferents. However, LSP4-2022 also reduced evoked monosynaptic IPSCs in CA1 pyramidal cells and, in contrast to its effect on SC-CA1 EPSPs, ADX71743 reversed the ability of high-frequency stimulation of SC afferents to reduce IPSC amplitudes. Furthermore, blockade of mGlu7 prevented induction of LTP at the SC-CA1 synapse and activation of mGlu7 potentiated submaximal LTP. Together, these data suggest that mGlu7 serves as a heteroreceptor at inhibitory synapses in area CA1 and that the predominant effect of activation of mGlu7 by stimulation of glutamatergic afferents is disinhibition, rather than reduced excitatory transmission. Furthermore, this mGlu7-mediated disinhibition is required for induction of LTP at the SC-CA1 synapse, suggesting that mGlu7 could serve as a novel therapeutic target for treatment of cognitive disorders.",
keywords = "Glutamate, Hippocampus, LTP, mGlu, mGlu7, mGlur7",
author = "Rebecca Klar and Walker, {Adam G.} and Dipanwita Ghose and Grueter, {Brad A.} and Engers, {Darren W.} and Hopkins, {Corey R} and Lindsley, {Craig W.} and Zixiu Xiang and Conn, {P. Jeffrey} and Niswender, {Colleen M.}",
year = "2015",
month = "5",
day = "13",
doi = "10.1523/JNEUROSCI.4543-14.2015",
language = "English (US)",
volume = "35",
pages = "7600--7615",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "19",

}

TY - JOUR

T1 - Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SCCA1 synapses in the hippocampus

AU - Klar, Rebecca

AU - Walker, Adam G.

AU - Ghose, Dipanwita

AU - Grueter, Brad A.

AU - Engers, Darren W.

AU - Hopkins, Corey R

AU - Lindsley, Craig W.

AU - Xiang, Zixiu

AU - Conn, P. Jeffrey

AU - Niswender, Colleen M.

PY - 2015/5/13

Y1 - 2015/5/13

N2 - Of the eight metabotropic glutamate (mGlu) receptor subtypes, only mGlu7 is expressed presynaptically at the Schaffer collateral (SC)-CA1 synapse in the hippocampus in adult animals. Coupled with the inhibitory effects of Group III mGlu receptor agonists on transmission at this synapse, mGlu7 is thought to be the predominant autoreceptor responsible for regulating glutamate release at SC terminals. However, the lack of mGlu7-selective pharmacological tools has hampered direct testing of this hypothesis. We used a novel, selective mGlu7-negative allosteric modulator (NAM), ADX71743, and a newly described Group III mGlu receptor agonist, LSP4-2022, to elucidate the role of mGlu7 in modulating transmission in hippocampal area CA1 in adult C57BL/6J male mice. Interestingly, although mGlu7 agonists inhibit SC-CA1 EPSPs, we found no evidence for activation of mGlu7 by stimulation of SC-CA1 afferents. However, LSP4-2022 also reduced evoked monosynaptic IPSCs in CA1 pyramidal cells and, in contrast to its effect on SC-CA1 EPSPs, ADX71743 reversed the ability of high-frequency stimulation of SC afferents to reduce IPSC amplitudes. Furthermore, blockade of mGlu7 prevented induction of LTP at the SC-CA1 synapse and activation of mGlu7 potentiated submaximal LTP. Together, these data suggest that mGlu7 serves as a heteroreceptor at inhibitory synapses in area CA1 and that the predominant effect of activation of mGlu7 by stimulation of glutamatergic afferents is disinhibition, rather than reduced excitatory transmission. Furthermore, this mGlu7-mediated disinhibition is required for induction of LTP at the SC-CA1 synapse, suggesting that mGlu7 could serve as a novel therapeutic target for treatment of cognitive disorders.

AB - Of the eight metabotropic glutamate (mGlu) receptor subtypes, only mGlu7 is expressed presynaptically at the Schaffer collateral (SC)-CA1 synapse in the hippocampus in adult animals. Coupled with the inhibitory effects of Group III mGlu receptor agonists on transmission at this synapse, mGlu7 is thought to be the predominant autoreceptor responsible for regulating glutamate release at SC terminals. However, the lack of mGlu7-selective pharmacological tools has hampered direct testing of this hypothesis. We used a novel, selective mGlu7-negative allosteric modulator (NAM), ADX71743, and a newly described Group III mGlu receptor agonist, LSP4-2022, to elucidate the role of mGlu7 in modulating transmission in hippocampal area CA1 in adult C57BL/6J male mice. Interestingly, although mGlu7 agonists inhibit SC-CA1 EPSPs, we found no evidence for activation of mGlu7 by stimulation of SC-CA1 afferents. However, LSP4-2022 also reduced evoked monosynaptic IPSCs in CA1 pyramidal cells and, in contrast to its effect on SC-CA1 EPSPs, ADX71743 reversed the ability of high-frequency stimulation of SC afferents to reduce IPSC amplitudes. Furthermore, blockade of mGlu7 prevented induction of LTP at the SC-CA1 synapse and activation of mGlu7 potentiated submaximal LTP. Together, these data suggest that mGlu7 serves as a heteroreceptor at inhibitory synapses in area CA1 and that the predominant effect of activation of mGlu7 by stimulation of glutamatergic afferents is disinhibition, rather than reduced excitatory transmission. Furthermore, this mGlu7-mediated disinhibition is required for induction of LTP at the SC-CA1 synapse, suggesting that mGlu7 could serve as a novel therapeutic target for treatment of cognitive disorders.

KW - Glutamate

KW - Hippocampus

KW - LTP

KW - mGlu

KW - mGlu7

KW - mGlur7

UR - http://www.scopus.com/inward/record.url?scp=84929380172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929380172&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.4543-14.2015

DO - 10.1523/JNEUROSCI.4543-14.2015

M3 - Article

VL - 35

SP - 7600

EP - 7615

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 19

ER -